London: Relx Plc (LON:REL) Stock Has Just Had Its Hold Rating Reiterated by numis. Shares now Have a GBX 1585.00 Target

February 21, 2018 - By Stephen Andrade

Relx Plc (LON:REL) Rating Reaffirmed

Research analysts at numis now has a GBX 1585.00 target price on Relx Plc (LON:REL). numis and their recent target price indicates a potential upside of 5.60 % from the company’s stock close price. The rating has been revealed to clients and investors in an analyst note on 20 February.

RELX PLC (LON:REL) Ratings Coverage

Among 19 analysts covering Reed Elsevier PLC (LON:REL), 14 have Buy rating, 1 Sell and 4 Hold. Therefore 74% are positive. Reed Elsevier PLC has GBX 1990 highest and GBX 20 lowest target. GBX 1676.67’s average target is 11.15% above currents GBX 1508.5 stock price. Reed Elsevier PLC had 155 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by Barclays Capital on Friday, July 7 with “Overweight”. The stock of RELX PLC (LON:REL) has “Buy” rating given on Friday, January 20 by Liberum Capital. As per Thursday, July 23, the company rating was maintained by Investec. The rating was maintained by Liberum Capital on Thursday, March 2 with “Buy”. On Friday, January 13 the stock rating was maintained by Goldman Sachs with “Neutral”. Liberum Capital maintained the stock with “Buy” rating in Wednesday, July 12 report. The rating was maintained by Barclays Capital on Thursday, January 28 with “Overweight”. The company was maintained on Thursday, February 23 by Liberum Capital. The company was maintained on Friday, July 24 by BNP Paribas. The stock of RELX PLC (LON:REL) has “Buy” rating given on Friday, February 26 by Societe Generale.

The stock increased 1.04% or GBX 15.5 during the last trading session, reaching GBX 1508.5. About 2.29M shares traded. RELX PLC (LON:REL) has 0.00% since February 21, 2017 and is . It has underperformed by 16.70% the S&P500.

RELX PLC provides information and analytics for professional and business clients in North America, Europe, and internationally. The company has market cap of 30.06 billion GBP. The company's Scientific, Technical & Medical segment offers information, analytics, and tools that help clients make decisions. It has a 18.51 P/E ratio. This segment provides research, reference, and education content; and database and decision tools for scientists, academic institutions, educators, research leaders and administrators, medical researchers, doctors, nurses, and allied health professionals and students, as well as hospitals, research institutions, health insurers, managed healthcare organizations, research-intensive firms, and governments.

More important recent RELX PLC (LON:REL) news were published by: which released: “RELX -2.5% as Morgan Stanley rates it fully valued” on January 22, 2018, also published article titled: “RELX Group Announces Definitive Agreement to Acquire ThreatMetrix”, published: “Announcement of Non-Discretionary Share Buyback Programme” on February 15, 2018. More interesting news about RELX PLC (LON:REL) was released by: and their article: “Form 6-K RELX PLC For: Feb 19 Filed by: RELX NV” with publication date: February 19, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.